Insomnia Studies
Insomnia
Phase 2/3Active
Key Facts
About Pacific Clinical Research Medical Group
Pacific Clinical Research Medical Group is a long-established, private clinical research site organization that conducts Phase II-IV clinical trials for pharmaceutical sponsors, predominantly in psychiatry and neurology. Its business model is service-based, generating revenue by contracting with sponsors to recruit patients, administer trial protocols, and collect data. The company operates from a single physical site in Southern California and leverages its experienced medical team to attract trial participants by offering complementary care and medication. It occupies a niche as an investigative site within the broader clinical trial ecosystem.
View full company profileTherapeutic Areas
Other Insomnia Drugs
| Drug | Company | Phase |
|---|---|---|
| Cannabidiol Soft‑Gel Capsule | Avecho Biotechnology | Phase 3 |
| Nexalin Device | Nexalin Technology | Pivotal Trial |
| SILENOR | Currax Pharmaceuticals | Approved |
| CLM-IN01 | Closed Loop Medicine | Pre-commercial (UKCA/CE marked) |
| Levroso Long (Diphenhydramine/Melatonin) | NovaMedica | Approved |
| HS-10384 | Hansoh Pharma | Phase III |
| CEL-101 (C-122) | Celon Pharma | Phase II |
| CGS-2 | Canopy Growth | Phase II |